TAK-828F
TAK-828F is a potent, selective, and orally available retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonist (binding IC50=1.9 nM, reporter gene IC50=6.1 nM). TAK-828F shows excellent RORγt isoforms selectivity (>5000-fold selectivity against human RORα and RORβ).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1854901-94-2
- 分子式: C28H32FN3O5
- 分子量:509.57
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
IC50: 1.9 nM (RORγt, binding IC50), 6.1 nM (RORγt, reporter gene IC50)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| PBMC | IC50 |
102 nM
Compound: 37; TAK-828
|
Inhibition of IL-17 production in human PBMC
Inhibition of IL-17 production in human PBMC
|
[PMID: 30010338] |
| PBMC | IC50 |
9.5 nM
Compound: 37; TAK-828
|
Decrease in Tc17 cell differentiation in CD8+ T cells from human PBMC cells cultured under the Tc17-skewing conditions measured after 6 days
Decrease in Tc17 cell differentiation in CD8+ T cells from human PBMC cells cultured under the Tc17-skewing conditions measured after 6 days
|
[PMID: 30010338] |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mice with IL-23-induced cytokine expression model[1]
-
Dosage:0.3, 1, and 3 mg/kg
-
Administration:Orally administered; b.i.d.; 28 days
-
Result:Showed robust and dose-dependent inhibition of IL-17A expression (ED80=0.5 mg/kg).
化学情報
-
CAS 番号 1854901-94-2
-
分子量 509.57
-
分子式 C28H32FN3O5
-
SMILES
CC1(C)C2=C(F)C=C(NC([C@@H]3N(C([C@@H]4C[C@H](CC(O)=O)C4)=O)CCC5=C3C=CC(OC)=N5)=O)C=C2CC1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)